Anti-viral drug telaprevir improves response.

Anti-viral drug telaprevir improves response, halves duration of hepatitis C treatment The addition of the anti-viral medication telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and raise the number of patients who could be cured of their disease, according to the results of study coordinated by investigators from the Duke Clinical Analysis Institute more info . Regular treatment for the most common type of hepatitis C is definitely 48 weeks of a combined mix of two drugs, peginterferon alfa-2a and ribavirin, which cures not even half of individuals and has significant unwanted effects that make it very difficult for some individuals to keep their treatment, said John McHutchison, M.D., a hepatologist and gastroenterologist and researcher at the DCRI, and lead investigator upon this scholarly study.

James Kamau, coordinator of the Kenya Treatment Access Movement, said antiretroviral applications have to include food as part of their support to HIV-positive people. Most antiretroviral programs started with the essential goal of keeping people alive, but drugs alone cannot keep [an HIV-positive person] alive, Kamau said, adding, If you don’t feed people, they can’t regain enough strength to work and make a living. Kamau noted that in Kenya, poverty is definitely a huge problem. He added, Women in particular suffer because they’re responsible for looking after and feeding people in the home, so when no means are had by them to get this done the whole household suffers.

Other Posts From Category "tools":

Related Posts